Pharvaris said it’s on track to launch a pivotal Phase 3 trial of deucrictibant to treat and prevent swelling…
Articles by Lindsey Shapiro, PhD
Ekterly (sebetralstat) has been approved in the U.K. for treating swelling attacks on demand in people with hereditary…
The U.S. Food and Drug Administration (FDA) has approved sebetralstat for the on-demand treatment of swelling attacks in adults…
The European Commission has approved Andembry (garadacimab) as a monthly treatment for preventing swelling attacks in people with…
CSL’s garadacimab, under the brand name Andembry, has been approved in the U.K. and Australia for the routine prevention…
An investigational gene-editing therapy for hereditary angioedema (HAE) called P-KLKB1-101 showed it could safely work as intended in preclinical…
Initiating treatment with sebetralstat within a few minutes of the start of a hereditary angioedema (HAE) attack was…
Treatment with deucrictibant continued to successfully prevent and treat swelling attacks in people with hereditary angioedema (HAE), according…
The U.S. Food and Drug Administration (FDA) has agreed to review Kalvista Pharmaceuticals’ application seeking the approval of…
Hereditary angioedema (HAE) patients in South Australia are generally satisfied with their prophylactic (preventive) treatment regimens, a study found.